Choisissez votre pays / Select your country

Ninalia NIPT The prenatal trisomy screening test based on maternal blood sample

Monitoring your patients

Patient’s journey according to the decision tree:

Screening
Non-invasive sample
  • Ultrasound
  • Maternal Serum Markers  (MSM)
  • Non-Invasive Prenatal Testing (NIPT)
Diagnosis
Invasive sample
  • Amniocentesis
  • Chorionic villus sampling

Trisomy 21 diagnostic strategy with NIPT

N.B: For signs on ultrasound or risk greater than 1/10 according to maternal serum markers, confirmation of the diagnosis by fœtal karyotype testing on invasive sample is required.

Please contact Eurofins Biomnis geneticists at international@eurofins-biomnis.com should you need further information.

What are the Ninalia’s benefit for the patient and her physician ?

Autosomal aneuploidies can, for most chromosomes, be found in the form of mosaics. Thus, when an anomaly is observed, the healthcare professional will refer, depending on the anomaly found, to ultrasound monitoring, and/or monitoring of the risk of pre-eclampsia, and/or possibly towards an invasive procedure to study the karyotype.

The result of the test can thus, by directing the monitoring of the pregnancy, make it possible to avoid a fetal loss in late pregnancy.

When an invasive procedure is warranted, knowledge of the suspected abnormality helps the healthcare professional specify the confirmatory techniques to be used (karyotype, FISH, DNA chip) and the type of tissue to be studied (chorionic villi or amniotic fluid).

Finally, a structural imbalance of more than 7 megabases, proven in the fetus, may not necessarily be accompanied by ultrasound call signs at the end of pregnancy but may be associated with clinical signs at birth, or at a later date.

Monitoring your patients Monitoring your patients

Vous avez refusé de partager votre position.
Désolé. Nous n'arrivons pas à savoir où vous êtes...
Il faut nous autoriser à voir votre position...
Votre navigateur ne possède pas cette fonctionnalité.

Partner laboratories

out of laboratories in total out of laboratories in total